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To the Editor: Chikungunya 
virus (CHIKV) is an emerging 
arthropodborne alphavirus of the 
family Togaviridae (1). The most 
common clinical manifestations of 
infection with CHIKV are abrupt onset 
of fever, headache, back pain, myalgia, 
and arthralgia affecting mainly the 
extremities; in ≈50% of patients, 
a rash develops, and relapsing and 
incapacitating arthralgia is common 
(1). Three CHIKV lineages have been 
characterized: West African, Asian, 
and East/Central/South African (1,2). 
The strain currently circulating in 
the Caribbean belongs to the Asian 
lineage (2).
In the Pacific region in 2011, 
a CHIKV outbreak was reported 
in New Caledonia (3). Additional 
outbreaks have been reported in 
Papua New Guinea in June 2012 (4), 
Yap State in August 2013 (5), and 
in the Kingdom of Tonga in April 
2014 (6). In the Caribbean region, 
cases of CHIKV infection were 
reported in the French part of Saint 
Martin Island in December 2013, 
after which CHIKV rapidly spread 
to other Caribbean islands, including 
Guadeloupe (2), where by the end of 
May 2014 it had caused an estimated 
23,100 infections. 
On May 25, 2014, a healthy 
60-year-old woman returned to French 
Polynesia after a 6-month stay with 
her husband’s family in Guadeloupe, 
where she had been in contact with 
family members who reportedly had 
chikungunya. On the first night after 
arriving back home in French Polynesia, 
she noted headache, transient high 
fever, and mild arthralgia of the knees. 
The next day, she sought care from 
her general practitioner for weakness, 
headache, and severe polyarthralgia 
(wrists, fingers, knees, toes). Physical 
examination revealed only swollen 
fingers and toes; the patient was not 
febrile. Blood samples were collected, 
and the patient was administered 
acetaminophen and corticosteroids. 
Her headache persisted until day 3, and 
arthralgia persisted until day 4.
Laboratory tests revealed 
lymphopenia (589 × 106 cells/L) and 
slightly elevated C-reactive protein 
(14.2 mg/L) and liver enzyme levels 
(aspartate aminotransferase 44 IU/L, 
gamma-glutamyl transferase 58 IU/L). 
CHIKV infection was confirmed by a 
specific real-time reverse transcription 
PCR (rRT-PCR) with previously 
reported primers and probe (7) and 
by partial sequencing of the E1 gene 
(GenBank accession no. KJ939333). 
Phylogenetic analysis (Figure) showed 
that the virus strain isolated from the 
patient was most closely related to strains 
isolated in the British Virgin Islands 
in 2014 (VG14/99659, accession no. 
KJ451624), Yap State, Federated States 
of Micronesia, in 2013 (FM13/3807, 
accession no. KJ451622), and Zhejiang 
Province, China, in 2012 (CN12/chik-
sy, accession no. KF318729), with 
100%, 99.89%, and 99.78% homology, 
respectively, thereby confirming its 
inclusion in the Asian lineage. A blood 
sample from the patient was inoculated 
into Vero and Aedes albopictus C6/36 
cells. Cells were incubated for 6 days, 
after which time both supernatants 
were removed and tested. RT-PCR, as 
described above, gave positive results 
for CHIKV. 
After CHIKV infection was 
confirmed, the case was immediately 
reported to health authorities in 
French Polynesia. Vector control 
measures were immediately im-
plemented and included individual 
protection against mosquito bites 
(mosquito repellents) for the patient 
and her close social and family 
contacts and collective protection 
(insecticide spraying and breeding 
site elimination) targeting the house 
of the patient and the areas that she 
had visited. Written informed consent 
was obtained from the patient before 
publication of this case report.
Arbovirus diseases are endemic 
to French Polynesia. Dengue virus 
serotypes 1 and 3 have been co-
circulating since 2013 (8); and, from 
October 2013 through April 2014, a 
large outbreak of Zika virus infection 
occurred (9). Because this case provides 
evidence of the possible emergence of 
CHIKV in French Polynesia, health 
authorities and health care workers in 
French Polynesia were immediately 
alerted and prepared to detect local 
transmission of CHIKV infection.
CHIKV is transmitted by mos-
quitoes of the Aedes species, especially 
Ae. aegypti and Ae. albopictus (1,2). The 
risk for emergence of a chikungunya 
outbreak in French Polynesia is high 
because of the presence of 2 potential 
vectors: Ae. aegypti mosquitoes, 
vectors of CHIKV in New Caledonia 
(3) and in Guadeloupe (2), and Ae. 
polynesiensis mosquitoes, potential 
CHIKV vectors as suggested by 
experimental infections  (10).
The role of foreign travel in 
spreading arboviruses between French 
overseas territories is highlighted 
by the observation that the CHIKV-
infected patient reported here returned 
from Guadeloupe and by a previous 
report that the 2013 outbreak of dengue 
virus type 3 in French Polynesia 
was caused by a virus introduced 
from French Guiana (8). Zika fever 
was reported in French Polynesia 
in October 2013; within the next 6 
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months, 28,000 suspected cases were 
reported (9), but the index patient was 
not identified. 
As soon as this case of chikun-
gunya in French Polynesia was 
reported, control measures were 
applied; as of 4 weeks later, no 
autochthonous cases have been 
reported. However, because the 
French Polynesia population has 
not been exposed to CHIKV, as it 
had not been exposed to ZIKV, the 
possibility of evolution toward a large 
CHIKV outbreak cannot be excluded. 
Reinforced epidemiologic surveillance 
and laboratory capacities are needed 
for determining whether chikun- 
gunya will extend further in French 
Polynesia and in the Pacific region.
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Figure.	Phylogenetic	 analysis	 of	 the	 chikungunya	 virus	 strain	 isolated	 from	a	 patient	 in	
French	Polynesia,	May	2014.	The	evolutionary	history	was	inferred	by	using	the	maximum-
likelihood	method	based	on	 the	Kimura	2-parameter	model.	The	percentage	of	 trees	 in	
which	the	associated	taxa	clustered	together	is	shown	for	values	>90	next	to	the	branches	
(1,000	 replicates).	 Evolutionary	 analyses	 were	 conducted	 by	 using	 MEGA	 software,	
version	6	(http://www.megasoftware.net).	Each	strain	 is	 labeled	by	country	(International	
Organization	 for	 Standardization	 2-letter	 country	 codes,	 http://www.iso.org/iso/home/
standards/country_codes.htm)	 and	 date	 of	 origin	 /strain	 name/GenBank	 accession	
number.	 Black	 diamond	 indicates	 the	 chikungunya	 virus	 strain	 from	 French	 Polynesia;	
black	triangles	 indicate	strains	from	other	Pacific	 islands.	Scale	bar	 indicates	number	of	
substitutions	per	site.
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